India  
 
NewsR.in

United States: Antitrust & Competition Life Sciences Year In Review 2023 - Goodwin Procter LLP

Mondaq Tuesday, 5 March 2024
Despite increasingly aggressive rhetoric from the agencies, 2022 was largely characterized as "business as usual" in the antitrust world.
0
shares		ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

United States: Remaining Steadfast: Goodwin's Life Sciences In 2023 - Goodwin Procter LLP

 This annual recap highlights Goodwin's continued determination and agility as a full-service, integrated global practice. Committed to being a global destination...
Mondaq